(Your details are not shared with 3rd parties)
(Please allow 1-3 business days UK)
(No returns)
Retatrutide is an experimental, once a week injectable medication developed by 'Eli Lilly' that is currently in late-stage Phase 3 clinical trials. Nicknamed the “triple-G” or “Godzilla” of weight-loss drugs, it uniquely targets three hormone receptors—GLP-1, GIP, and Glucagon— in order to powerfully suppress appetite - increase energy expenditure and break down fat
Your review appreciation cannot be sent
Report comment
Report sent
Your report cannot be sent
Write your review
Review sent
Your review cannot be sent
check_circle
check_circle